Identification of chemicals targeting dementia genes and pathways in the Comparative Toxicogenomics Database

Read full text
Authors: Scarlet M Cockell, Sean M. Harris, Rachel K. Morgan, Gary J. Patti, Erin B. Ware, Kelly M. Bakulski
Cited by: 0
References: 79

Abstract

Abstract INTRODUCTION Dementia is a public health challenge and exposures likely contribute to risk, though many have not been evaluated. We screened chemicals for enrichment with dementia genes and related pathways. METHODS We obtained gene lists from Agora and the Comparative Toxicogenomics Database (CTD) for 1008 chemicals and nine dementia‐related pathways (e.g., Alzheimer's disease, tauopathies). We tested pairwise chemical–dementia gene enrichment using Fisher exact tests and proportional reporting ratios (PRRs), accounting for multiple comparisons with false discovery rate (FDR < 1 × 10 −6 ). RESULTS Of the chemicals tested, 817 (81.1%) were enriched for at least one dementia pathway and 71 with all nine pathways, including benzo(a)pyrene, ethanol, paraquat, and particulate matter. We observed 295 chemicals enriched for Alzheimer's disease, including sodium arsenite (PRR = 57.9) and 305 enriched for tauopathies, including bisphenol A (PRR = 37.7). DISCUSSION We identified chemicals enriched for dementia pathways, suggesting broad classes of chemicals contribute to dementia.

Fields of Study & Subjects

Alzheimer's disease research and treatments Carcinogens and Genotoxicity Assessment Metabolomics and Mass Spectrometry Studies

Publication details

Journal / source
Alzheimer s & Dementia
Volume
22
Issue
8
Pages
e71775–e71775
Publication date
1 August 2026
Language
EN